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Cystic fibrosis (CF) is characterised by chronic airway infection with bacteria and
fungi. Infections caused by Scedosporium/Lomentospora species can occur and are
difficult to treat. Moulds belonging to the genus Scedosporium/Lomentospora are
detected most frequently in respiratory samples of patients with CF, next to
Aspergillus spp. Our aim was to define pulmonary fungal infections due to
Scedosporium/Lomentospora in CF and to study the antimycotic treatment.
In this multicentre study (12 centres; duration January 2008 to December 2014) 31
patients with a lung infection caused by moulds of the genus
Scedosporium/Lomentospora were included. 36 courses of antifungal treatment
were documented. Scedosporium apiospermum sensu stricto accounted for 48.4% of
cases. In 20/31 patients a therapeutic response under antimycotics (median duration
3.9 months) was achieved. Triple and double therapy was significantly more
effective compared to monotherapy regarding FEV1, radiology, and symptoms.
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